Guerin; David Joseph

Patent Applications and Registrations

Patent applications and USPTO patent grants for Guerin; David Joseph.The latest application filed is for "pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors".

Company Profile

8.12.14

Guerin; David Joseph - Natick MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors Grant 11,325,917 - Guerin , et al. May 10, 2	2022-05-10
Pyrrolo And Pyrazolopyrimidines As Ubiquitin-specific Protease 7 Inhibitors App 20210332052 - Ioannidis; Stephanos ; et al.	2021-10-28
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors Grant 10,934,299 - Ioannidis , et al. March 2, 2	2021-03-02
Thienopyrazine Carboxamides As Ubiquitin-specific Protease Inhibitors App 20210047343 - Guerin; David Joseph ; et al.	2021-02-18
Thienopyridine carboxamides as ubiquitin-specific protease inhibitors Grant 10,913,753 - Guerin , et al. February 9, 2	2021-02-09
Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors Grant 10,889,592 - Guerin , et al. January 12, 2	2021-01-12
Thienopyridine Carboxamides as Ubiquitin-Specific Protease Inhibitors App 20200017525 - Guerin; David Joseph ; et al.	2020-01-16
Pyrrolo And Pyrazolopyrimidines As Ubiquitin-specific Protease 7 Inhibitors App 20190367525 - Ioannidis; Stephanos ; et al.	2019-12-05
Thienopyrazine Carboxamides as Ubiquitin-Specific Protease Inhibitors App 20190359628 - Guerin; David Joseph ; et al.	2019-11-28
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors Grant 10,377,760 - Ioannidis , et al. A	2019-08-13
Pyrrolo And Pyrazolopyrimidines As Ubiquitin-specific Protease 7 Inhibitors App 20180339988 - Ioannidis; Stephanos ; et al.	2018-11-29
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors Grant 9,902,728 - Ioannidis , et al. February 27, 2	2018-02-27
Pyrrolo And Pyrazolopyrimidines As Ubiquitin-specific Protease 7 Inhibitors App 20160185785 - Ioannidis; Stephanos ; et al.	2016-06-30
Compounds that are ERK inhibitors Grant 9,023,865 - Lim , et al. May 5, 2	2015-05-05
Bicyclic diamines as janus kinase inhibitors Grant 8,937,077 - Guerin , et al. January 20, 2	2015-01-20
Novel Compounds That Are Erk Inhibitors App 20140296203 - Lim; Jongwon ; et al.	2014-10-02
Aminopyrimidines as SYK Inhibitors App 20140243290 - Altman; Michael D. ; et al.	2014-08-28
Aminopyrimidines as SYK inhibitors Grant 8,551,984 - Altman , et al. October 8, 2	2013-10-08
Bicyclic Diamines As Janus Kinase Inhibitors App 20130225577 - Guerin; David Joseph ; et al.	2013-08-29
Aminopyrimidines As Syk Inhibitors App 20120277192 - Altman; Michael D. ; et al.	2012-11-01
Aminopyrimidines As Syk Inhibitors App 20110245205 - Altman; Michael D. ; et al.	2011-10-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.